Taylor, P.C.; Bushmakin, A.G.; Cappelleri, J.C.; Young, P.; Germino, R.; Merola, J.F.; Yosipovitch, G.
Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis. J. Clin. Med. 2021, 10, 4081.
https://doi.org/10.3390/jcm10184081
AMA Style
Taylor PC, Bushmakin AG, Cappelleri JC, Young P, Germino R, Merola JF, Yosipovitch G.
Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis. Journal of Clinical Medicine. 2021; 10(18):4081.
https://doi.org/10.3390/jcm10184081
Chicago/Turabian Style
Taylor, Peter C., Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, and Gil Yosipovitch.
2021. "Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis" Journal of Clinical Medicine 10, no. 18: 4081.
https://doi.org/10.3390/jcm10184081
APA Style
Taylor, P. C., Bushmakin, A. G., Cappelleri, J. C., Young, P., Germino, R., Merola, J. F., & Yosipovitch, G.
(2021). Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis. Journal of Clinical Medicine, 10(18), 4081.
https://doi.org/10.3390/jcm10184081